Dual GIP/GLP-1 Drug Linked to Fewer Deaths in Real-World Liver Disease Study

(MedPage Today) — PHOENIX — Use of tirzepatide (Mounjaro, Zepbound) was associated with significantly lower risks of death, hospitalization, and major cardiovascular events compared with semaglutide (Ozempic, Wegovy) in high-risk patients with…

Source link : https://www.medpagetoday.com/meetingcoverage/acg/118194

Author :

Publish date : 2025-10-28 21:11:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

Dual GIP/GLP-1 Drug Linked to Fewer Deaths in Real-World Liver Disease Study

Delaying Gallbladder Removal After Bile Duct Stones May Be Riskier

Difficult-to-Treat Rheumatoid Arthritis: Is Prevention Feasible?

Related Posts

Mixed Results With Metformin for Men on ADT for Prostate Cancer

Difficult-to-Treat Rheumatoid Arthritis: Is Prevention Feasible?

Modestly Higher Risk for Autoimmune Disease Linked to HT

Delaying Gallbladder Removal After Bile Duct Stones May Be Riskier

First 7-Year Report of Low-Risk TAVR Reassures, With Finish Line Now in Sight

Pre-op Immunotherapy for Head and Neck Cancer Rising

Mixed Results With Metformin for Men on ADT for Prostate Cancer

Difficult-to-Treat Rheumatoid Arthritis: Is Prevention Feasible?

Dual GIP/GLP-1 Drug Linked to Fewer Deaths in Real-World Liver Disease Study

Modestly Higher Risk for Autoimmune Disease Linked to HT

Delaying Gallbladder Removal After Bile Duct Stones May Be Riskier

First 7-Year Report of Low-Risk TAVR Reassures, With Finish Line Now in Sight

Pre-op Immunotherapy for Head and Neck Cancer Rising

What a ‘Private Equity Government’ Means for Public Health

Categories

Archives